[Role of immunologic indicators in clinico-laboratory findings in the planning of therapeutic regimen and evaluation of its effectiveness in rheumatoid arthritis].
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D015122:Mercaptopurine / Q000008:administration & dosage; D010396:Penicillamine / Q000008:administration & dosage
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D003520:Cyclophosphamide; D015122:Mercaptopurine; D010396:Penicillamine
Mesto immunologicheskikh pokazateleĭ v kliniko-laboratornom komplekse pri sostavlenii skhemy lecheniia i otsenke ee ĕffektivnosti u bol'nykh revmatoidnym artritom.